FDA approves new treatment option for patients with HER2-positive breast cancer
Enhertu targets the changes in HER2 that help the cancer grow, divide and spread
Enhertu targets the changes in HER2 that help the cancer grow, divide and spread
Hall A2 - Booth #109, analytica, May 10-13, 2016, Munich, Germany
Rugged, stable, and waterproof
The Barostim Neo System was given a Breakthrough Device designation by the FDA
Hear how David Foley, Principal Scientist at Pfizer, uses reaction monitoring NMR spectroscopy
Advances in microscopy reveal source of phonons’ puzzling behavior
Watch this on-demand webinar to learn about the key factors that play a role in the ability of low-field NMR to analyze polymer systems
Safe, accurate, reproducible and validatable sterilization with Systec
Find application notes and information resources on modern cation analysis
Scientists based at the Moscow Institute of Physics and Technology have designed a portable device for rapid correction of hemostasis abnormalities – SelectScience editors find out more
The drug works by targeting the protein responsible for the death of heart cells during an attack
Catch Specac at Pittcon, booth 4141 to learn about all their latest innovations